Can eye movements ease depression? new study investigates
NCT ID NCT07033741
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will observe 40 adults in Italy receiving EMDR therapy for depressive symptoms. Researchers want to find out which factors—like personal beliefs, anxiety, or the therapist-patient relationship—influence how well the therapy works. The goal is to better understand how to personalize EMDR for depression, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Eye Movement Desensitization and Reprocessing (EMDR) therapy
- What this could lead to
- If successful, this study could identify which patient factors make EMDR most effective for depression, helping tailor therapy to individuals.
- What could go wrong
- This is a small observational study (40 participants) without a control group, so results may not apply broadly. It aims to understand, not prove, treatment effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION, ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Turin
RECRUITINGTurin, Turin, 10123, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Unlocking the mystery of persistent pain after breast surgery
- Can surgery for a bowel disorder also lift depression and anxiety?
- Can magnetic pulses to the brain calm End-of-Life distress?
- Floating away trauma: could Sensory-Deprivation tanks ease PTSD in healthcare heroes?
- Exercise as medicine: study tests whether group workouts boost mental health in hospitalized patients
- Microdosing magic mushrooms: could tiny psilocybin doses soothe End-of-Life anxiety?